German Entertainment Stock News

Wondering if Bayer is finally a genuine value opportunity after years of frustration, or just another value trap in disguise? This article will walk through the evidence with you. After a long stretch of underperformance over 3 and 5 years, the stock has surged recently, climbing about 9.3% over the last week, 26.0% over the last month, and 71.8% year to date. That sharp move has come alongside renewed investor focus on Bayer's restructuring efforts and ongoing litigation over legacy...

If you are wondering whether PUMA’s beaten-up share price is quietly turning into a value opportunity, this article will walk you through whether the stock now looks cheap or just risky. After a rough longer-term slide, with the share price still down 53.2% over the last year, PUMA has bounced 6.3% in the past week and 25.4% over the last month, suggesting that market sentiment might be starting to shift. This recent rebound comes as investors refocus on the strength of the PUMA brand and...

Metro (HMSE:B4B) has capped FY 2025 with fourth quarter revenue of €8.5 billion and a basic EPS of €-0.25, as net income excluding extra items landed at €-96 million. Over the last few quarters the company has seen revenue move from €8.0 billion in Q4 2024 to €8.5 billion in Q4 2025, while EPS shifted from €-0.21 to €-0.25 and trailing twelve month EPS sits at €-0.60 alongside net income of €-218 million on €32.4 billion of revenue. This points to a business that is still wrestling with thin,...

Aurubis (XTRA:NDA) has wrapped up FY 2025 with fourth quarter revenue of €4.4 billion alongside EPS of €1.04, setting the tone for a year where profit margins stayed under pressure but remained positive. Over the past six quarters, the company has seen revenue move from €4.2 billion in Q4 2024 to a range between roughly €4.2 billion and €5.0 billion per quarter, while quarterly EPS has swung between €1.04 and €5.87, highlighting how sensitive earnings are to underlying margin shifts. With...

BASF (XTRA:BAS) is back in the spotlight as battery metals lead Matthew Burford heads to the Resourcing Tomorrow conference in London, putting the companys long term electrification strategy under closer investor scrutiny. See our latest analysis for BASF. The upcoming conference appearances have caught investors attention, but BASF is still treading water, with a modestly positive year to date share price return and a relatively muted 1 year total shareholder return. This suggests momentum...

Siemens (XTRA:SIE) has quietly kept delivering for long term holders, with the stock up around 22% over the past year, even after a recent pullback over the past month. See our latest analysis for Siemens. That recent 1 month share price pullback of 5.73 percent comes after a strong year to date share price return of 21.72 percent and a 1 year total shareholder return of 22.03 percent. This suggests that momentum is cooling, while the longer term trend remains clearly positive. If Siemens...

Wondering if Deutsche Bank is still a bargain after its big run, or if you might be late to the party? This breakdown will help you decide whether the current price makes sense or is getting ahead of itself. The stock is up 1.4% over the last week and 84.3% year to date, with a massive 87.7% gain over the past year and 279.4% over five years, so the market has clearly re-rated the bank's prospects. Recent headlines have focused on Deutsche Bank's ongoing restructuring progress and renewed...

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...

Volkswagen Group recently appointed Ludwig Fazel as Head of Group Strategy, Group Product Strategy and the General Secretariat, while also facing a new U.S. patent infringement lawsuit over automated driving technologies filed by Perrone Robotics. This combination of a refreshed strategy leadership role and legal scrutiny around core autonomous driving software could influence how investors assess Volkswagen’s long-term technology roadmap and execution. We’ll now explore how Fazel’s expanded...

Wondering if Dr. Ing. h.c. F. Porsche is finally trading at a price that makes sense, or if the market is still misreading the story? Let us unpack what the current share price might really be saying about value. Over the last week the stock has climbed about 5.0%, adding to a 4.9% gain over the past month. Yet it is still down roughly 19.5% year to date and 16.4% over the last year, which suggests sentiment is still catching up with recent moves. Those swings sit against a backdrop of...

As European markets continue to show resilience, with the pan-European STOXX Europe 600 Index closing 2.35% higher and major single-country indexes also rising, investors are increasingly looking towards dividend stocks as a potential source of steady income amidst economic fluctuations. In this environment, a good dividend stock is often characterized by its ability to provide consistent payouts and maintain stability even when broader market conditions are unpredictable.

Most readers would already be aware that Friedrich Vorwerk Group's (ETR:VH2) stock increased significantly by 30% over...

With a price-to-earnings (or "P/E") ratio of 9.3x Mercedes-Benz Group AG ( ETR:MBG ) may be sending bullish signals at...

Key Insights Significant control over MEDICLIN by private companies implies that the general public has more power to...

For many, the main point of investing is to generate higher returns than the overall market. But every investor is...

2G Energy AG ( ETR:2GB ) shares have had a really impressive month, gaining 30% after a shaky period beforehand. The...

Most readers would already be aware that AS Latvijas Juras medicinas centrs' (MUN:UOM) stock increased significantly by...

One simple way to benefit from the stock market is to buy an index fund. But if you choose individual stocks with...

M1 Kliniken AG ( ETR:M12 ) shares have continued their recent momentum with a 32% gain in the last month alone. Looking...

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") above 19x, you may consider...

Bayer (XTRA:BAYN) has been busy, and the stock is catching more eyeballs as a result, with fresh headlines spanning FDA clearances, new trial launches, and regulatory filings across imaging, women’s health, and rare disease. See our latest analysis for Bayer. All of this clinical and regulatory progress seems to be feeding into sentiment, with a roughly 72.9% year to date share price return contrasting sharply with a negative three year total shareholder return. This suggests momentum is...

RWE (XTRA:RWE) has quietly turned into one of Europe’s stronger utility performers this year, with the stock up roughly 47% year to date and about 24% over the past 3 months. See our latest analysis for RWE. That surge in the share price this year looks less like a one off spike and more like momentum building, with investors warming to RWE’s renewables heavy shift and reassessing long term growth and risk. If RWE’s run has you rethinking the utilities space, it might be a good moment to...

Porsche Automobil Holding has implemented a tougher cost-cutting programme at its Zuffenhausen plant and Weissach R&D centre, including outsourcing, reduced bonuses, fewer apprentices, delayed EV launches, and now expects just 0–2% margins after reporting an operating loss of almost €1 billion in Q3 2025. This marked Porsche’s first quarterly loss since its IPO and coincided with its removal from the DAX index, underscoring investor concern about both execution risk in EVs and the pressure...

Uniper (XTRA:UN0) has quietly climbed about 16% over the past month, even as its one year return is still negative. That kind of rebound naturally raises questions about what has really changed. See our latest analysis for Uniper. Zooming out, that 15.5% one month share price return looks more like a short term reset after a tough stretch. The year to date share price is still notably negative and the five year total shareholder return is deeply underwater, suggesting momentum is only just...